Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06571136 · ClinicalTrials.gov registry record
The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19
A clinical trial of COVID-19, sponsored by N5 Sensors.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06571136 is a study of COVID-19 that is actively recruiting participants, run by N5 Sensors. The registered enrollment target is 60 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06571136, a study of COVID-19, is actively recruiting participants, sponsored by N5 Sensors.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The type and number of chemicals in exhaled breath are different in people with infection as compared to those without infection. In this study, the breath of people with and without COVID infection will be measured. Changes in the amount and type of chemicals in breath will be used to determine if an individual does or does not have COVID infection. If the measurements of breath are a reliable measure of COVID infection, this device may be used to rapidly screen people who are attending large public events (for example, music concert or baseball game) to minimize the spread of COVID at the event.
Conditions Studied
Study Locations (1)
Washington
- Providence Regional Medical Center Everett - Everett
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2025-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06571136
The ClinicalTrials.gov registry entry for NCT06571136 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is N5 Sensors, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT06571136 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06571136 about?
NCT06571136 is a clinical study titled "The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19". The type and number of chemicals in exhaled breath are different in people with infection as compared to those without infection. In this study, the breath of people with and without COVID infection will be measured. Changes in the amount and type of chemicals in breath will be used to determine if ...
What is the current status of trial NCT06571136?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2024-08-19. Estimated completion is 2025-02-26.
What conditions does trial NCT06571136 study?
This clinical trial studies the following conditions: COVID-19.
Who is sponsoring clinical trial NCT06571136?
This trial is sponsored by N5 Sensors, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06571136 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.